相关实验视频
Updated: May 31, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.4K
喘风险患病率和缩儿童的相关因素:使用喘预测指数的研究
Gartika Sapartini1, Gary W K Wong2, Agnes Rengga Indrati3
1Division of Allergy Immunology, Department of Child Health, Doctoral Study Program, Faculty of Medicine, Universitas Padjadjaran, Bandung 45363, West Java, Indonesia.
Medicina (Kaunas, Lithuania)
|January 25, 2025
概括
喘风险影响了4.7%的印尼缩儿童. 相关因素包括家庭过敏和养狗,这凸显了对儿童发育迟缓和喘发展的进一步研究的需要.
科学领域:
- 儿科 儿科 儿科
- 公共卫生 公共卫生
- 过敏和免疫学 过敏和免疫学
背景情况:
- 在5岁以下的印尼儿童中,发育迟缓的高患病率.
- 迟缓是喘障碍的已知危险因素之一.
- 关于喘风险和缩儿童的相关因素的研究有限.
研究的目的:
- 通过使用喘预测指数 (API) 来确定喘风险在缩儿童中的患病率.
- 为了确定与这一群体中喘风险相关的因素.
主要方法:
- 在印度尼西亚班敦格区卫生中心进行的横截面研究 (2021年10月 - 2022年1月).
- 包括422名年龄在24-59个月的缩儿童.
- 使用了父母的API和喘风险因素问卷.
主要成果:
- 4.7%的发育不良儿童符合喘风险的积极API标准.
- 显著的危险因素包括父母/兄弟姐妹的过敏病史和养狗.
- 阳性API结果与父母的喘,湿疹,过敏性鼻炎和频繁的喘息相关.
结论:
- 发育迟缓的儿童中喘风险患病率为4.7%.
- 关键的相关因素是家庭过敏史和养狗.
- 需要进一步的研究来理解这些关联.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma: Pathogenesis and Management
343
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
343
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
234
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
234

